Analyst Activity – HC Wainwright Raises Its Price Target On Cytokinetics (NASDAQ:CYTK) to

ME Staff
-
0

Analyst Ratings For Cytokinetics (NASDAQ:CYTK)

Today, HC Wainwright raised its price target on Cytokinetics (NASDAQ:CYTK) to per share.

Some recent analyst ratings include

  • 1/17/2018-Cantor Fitzgerald Reiterated Rating of Hold.
  • 11/29/2017-Needham & Company LLC was Downgraded by analysts at Needham & Company LLC from a “Strong-Buy ” rating to a ” Buy” rating. They now have a $12.00 price target on the stock, up previously from $22.00 .
  • 11/22/2017-Morgan Stanley Reiterated Rating of Overweight .
  • 11/21/2017-JMP Securities Reiterated Rating of Outperform.
  • 11/21/2017-Piper Jaffray Companies Reiterated Rating of Overweight.
  • 10/6/2017-Seaport Global Securities Reiterated Rating of Buy.

Recent Insider Trading Activity For Cytokinetics (NASDAQ:CYTK)
Cytokinetics (NASDAQ:CYTK) has insider ownership of 7.20% and institutional ownership of 73.61%.

  • On 1/16/2018 Caryn Gordon Mcdowell, Insider, sold 2,709 with an average share price of $9.00 per share and the total transaction amounting to $24,381.00.
  • On 11/2/2017 Caryn Gordon Mcdowell, Insider, sold 4,260 with an average share price of $12.94 per share and the total transaction amounting to $55,124.40.
  • On 11/1/2017 Fady Ibraham Malik, EVP, sold 7,321 with an average share price of $13.39 per share and the total transaction amounting to $98,028.19.
  • On 11/1/2017 Robert I Blum, CEO, sold 5,000 with an average share price of $13.51 per share and the total transaction amounting to $67,550.00.
  • On 10/6/2017 Caryn Gordon Mcdowell, Insider, sold 13,181 with an average share price of $15.49 per share and the total transaction amounting to $204,173.69.
  • On 10/2/2017 Robert I Blum, CEO, sold 5,000 with an average share price of $14.59 per share and the total transaction amounting to $72,950.00.
  • On 9/6/2017 Caryn Gordon Mcdowell, Insider, sold 10,131 with an average share price of $14.60 per share and the total transaction amounting to $147,912.60.

Recent Trading Activity for Cytokinetics (NASDAQ:CYTK)
Shares of Cytokinetics closed the previous trading session at 8.88 up +0.07 0.85% with shares trading hands.